Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 582730, 9 pages
http://dx.doi.org/10.1155/2014/582730
Research Article

The Molecular Mechanisms of Tanshinone IIA on the Apoptosis and Arrest of Human Esophageal Carcinoma Cells

1Cancer Research Institute, Zhejiang Cancer Hospital, No. 38 Guangji Road, Hangzhou, Zhejiang 310022, China
2Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Hangzhou, Zhejiang 310022, China

Received 7 November 2013; Revised 23 March 2014; Accepted 24 March 2014; Published 15 April 2014

Academic Editor: Wei Tang

Copyright © 2014 Jiang-Feng Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. G. D. Tran, X. Sun, C. C. Abnet et al., “Prospective study of risk factors for esophageal and gastric cancers in the Linxian General Population Trial cohort in China,” International Journal of Cancer, vol. 113, no. 3, pp. 456–463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Stewart, “Mechanisms of resistance to cisplatin and carbo-platin,” Critical Reviews in Oncology/Hematology, vol. 63, pp. 12–31, 2007. View at Google Scholar
  4. T. Zhang, T. Zhao, X. Xu, X. Gu, and Y. Pan, “Efficacy and side-effects of docetaxel combined with cisplatin on the treatment of local advanced esophageal cancer with concomitant radiation therapy,” Zhonghua Zhong Liu Za Zhi, vol. 32, no. 10, pp. 791–794, 2010. View at Google Scholar · View at Scopus
  5. R. Yang, A. Liu, X. Ma, L. Li, D. Su, and J. Liu, “Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation,” Journal of Cardiovascular Pharmacology, vol. 51, no. 4, pp. 396–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. H. Ren, Y. H. Tong, W. Xu, J. Ma, and Y. Chen, “Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression,” Phytomedicine, vol. 17, no. 3-4, pp. 212–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Liu, Y. Zhang, D. Lin, and R. Xiao, “Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis,” Oncology Reports, vol. 21, no. 4, pp. 1075–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Lu, P. Zhang, X. Zhang, and J. Chen, “Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer,” International Journal of Molecular Medicine, vol. 24, no. 6, pp. 773–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Chien, S. Kuo, Y. Chen, D. Chen, C. Cheng, and C. Su, “Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo,” Molecular Medicine Reports, vol. 5, no. 1, pp. 282–286, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Chen, D. Shi, S. Liu, and L. Zhong, “Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo,” Oncology Reports, vol. 27, no. 2, pp. 523–528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Xu, F. L. Cao, N. Y. Li, Y. Q. Liu, and Y. P. Li, “Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells,” Asian Pacific Journal of Cancer Prevention, vol. 14, pp. 173–177, 2013. View at Google Scholar
  12. C. Su and Y. Lin, “Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios,” International Journal of Molecular Medicine, vol. 22, no. 3, pp. 357–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Yan, S. Chien, S. Kuo, D. Chen, and C. Su, “Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression,” International Journal of Molecular Medicine, vol. 29, no. 5, pp. 855–863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Wang, X. Wang, S. Jiang et al., “Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells,” Journal of Neuro-Oncology, vol. 82, no. 1, pp. 11–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Pan, Y. Hung, P. Wang et al., “Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells,” Proteomics, vol. 10, no. 5, pp. 914–929, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Zhou, W. K. Chan, N. Xu et al., “Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest,” Life Sciences, vol. 83, no. 11-12, pp. 394–403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Gong, Y. Li, Y. Lu et al., “Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice,” International Journal of Cancer, vol. 129, no. 5, pp. 1042–1052, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. J. Levine, “p53, the cellular gatekeeper for growth and division,” Cell, vol. 88, no. 3, pp. 323–331, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Wu, L. Xu, N. Lin, and B. Liu, “UCN-01 induces S and G2/M cell cycle arrest through the p53/p21 (waf1) or CHK2/CDC25C pathways and cansuppress invasion in human hepatoma cell lines,” BMC Cancer, vol. 13, article 167, 2013. View at Google Scholar
  20. A. C. McDonald and R. Brown, “Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors,” British Journal of Cancer, vol. 78, no. 6, pp. 745–751, 1998. View at Google Scholar · View at Scopus
  21. R. Apweiler, “The Universal Protein resource (UniProt),” Nucleic Acids Research, vol. 36, no. 1, pp. D190–D195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Bendjennat, J. Boulaire, T. Jascur et al., “UV irradiation triggers ubiquitin-dependent degradation of p21 (WAF1) to promote DNA repair,” Cell, vol. 114, no. 5, pp. 599–610, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. D. O. Morgan, “Cyclin-dependent kinases: engines, clocks, and microprocessors,” Annual Review of Cell and Developmental Biology, vol. 13, pp. 261–291, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. W. G. Dunphy, “The decision to enter mitosis,” Trends in Cell Biology, vol. 4, no. 6, pp. 202–207, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Watanabe, M. Broome, and T. Hunter, “Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle,” The EMBO Journal, vol. 14, no. 9, pp. 1878–1891, 1995. View at Google Scholar · View at Scopus
  26. M. H. Cardone, N. Roy, H. R. Stennicke et al., “Regulation of cell death protease caspase-9 by phosphorylation,” Science, vol. 282, no. 5392, pp. 1318–1321, 1998. View at Google Scholar · View at Scopus
  27. Y. Zhang, R. Wei, X. Zhu, L. Cai, W. Jin, and H. Hu, “Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro,” Anti-Cancer Drugs, vol. 23, no. 2, pp. 213–219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Che, E. Park, Y. Zhao, W. Kim, and D. H. Sohn, “Tanshinone II A induces apoptosis and s phase cell cycle arrest in activated rat hepatic stellate cells,” Basic and Clinical Pharmacology and Toxicology, vol. 106, no. 1, pp. 30–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. N. Oltvai, C. L. Milliman, and S. J. Korsmeyer, “Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death,” Cell, vol. 74, no. 4, pp. 609–619, 1993. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Cheng and C. Su, “Tanshinone IIA may inhibit the growth of small cell lung cancer H146 cells by up-regulating the Bax/Bcl-2 ratio and decreasing mitochondrial membrane potential,” Molecular Medicine Reports, vol. 3, no. 4, pp. 645–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. X. Chen and S. Pervaiz, “Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells,” Cell Death and Differentiation, vol. 14, no. 9, pp. 1617–1627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Maglott, J. Ostell, K. D. Pruitt, and T. Tatusova, “Entrez gene: gene-centered information at NCBI,” Nucleic Acids Research, vol. 39, no. 1, pp. D52–D57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Chen, D. Shi, S. Liu, and L. Zhong, “Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo,” Oncology Reports, vol. 27, no. 2, pp. 523–528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Y. W. Lee, K. W. K. Liu, and J. H. K. Yeung, “Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells,” Cancer Letters, vol. 285, no. 1, pp. 46–57, 2009. View at Publisher · View at Google Scholar · View at Scopus